Boston Scientific Welcomes Launch Of Syntax Score Website

Boston Scientific Corporation (NYSE: BSX) welcomed the launch of a new website, http://www.syntaxscore.com, dedicated to the understanding and use of the SYNTAX Scoreâ„¢, a novel angiographic tool used to measure the complexity of coronary artery disease. The Company made the announcement at the annual EuroPCR Scientific Program in Barcelona.